Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world
Date
2019Journal
Expert Opinion on PharmacotherapyPublisher
Taylor and Francis LtdType
Article
Metadata
Show full item recordKeyword
antimicrobial resistancebeta-lactamase inhibitor
Extended-spectrum beta
gram-negative infections
lactamase
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072025712&doi=10.1080%2f14656566.2019.1663827&partnerID=40&md5=2a952d40358a6518df921afb58d8f6a7; http://hdl.handle.net/10713/10859ae974a485f413a2113503eed53cd6c53
10.1080/14656566.2019.1663827
Scopus Count
Collections
Related articles
- Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli.
- Authors: Sood S
- Issue date: 2013 Feb
- Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms.
- Authors: Schuetz AN, Reyes S, Tamma PD
- Issue date: 2018 Mar
- Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
- Authors: Afridi FI, Farooqi BJ
- Issue date: 2012 Jun
- Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
- Authors: López-Cerero L, Picón E, Morillo C, Hernández JR, Docobo F, Pachón J, Rodríguez-Baño J, Pascual A
- Issue date: 2010 Feb
- Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
- Authors: Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Kapil A
- Issue date: 2005 Nov